title: Serum potassium in dual renin-angiotensin-aldosterone system blockade.
authors.affiliation: Veterans Affairs Maryland Healthcare System and University of Maryland School of Medicine, Baltimore, Maryland, †Veterans Affairs Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Seliger
authors.forename: Linda F
authors.initials: LF
authors.lastname: Fried
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017706:Lisinopril / Q000627:therapeutic use*; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D011188:Potassium / Q000097:blood* / Q000652:urine*; D012084:Renin-Angiotensin System / Q000187:drug effects*; D013148:Spironolactone / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone; D017706:Lisinopril; D019808:Losartan; D011188:Potassium